On the other hand the brand new technologies are rather expensive, good quality human tissue samples hard to get so scrapping the bottom of the barrel trying to justify grant $$$ is unavoidable.
On the other hand the brand new technologies are rather expensive, good quality human tissue samples hard to get so scrapping the bottom of the barrel trying to justify grant $$$ is unavoidable.
Were there any major bug fixes that would impact their work in that time window? Maybe for them it is done instead of outdated.
Just to be clear: I am not saying that anything done in 2022 using hg19 is 100% wrong. Just that it is a bit like using a stretched shoelace 50cm (+/- 5cm) to measure your corridor when you have a decent tape measure in your pocket.
There are microarrays used in Big Science projects with ~1/3 of probes not matching human transcripts from latest ENSEMBL. Since most of them map to the current genome who knows what is the meaning of the signal from such probes. Unannotated exons? Retained introns? But some probes do not even map to the genome => some silly splicing error(?) packed in a plasmid in the 90ies?